DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Dimethicone is an investigational drug.
There have been 5 clinical trials for Dimethicone. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2013.
The most common disease conditions in clinical trials are Dermatitis, Psoriasis, and Peripheral Nervous System Diseases. The leading clinical trial sponsors are University of British Columbia, G. Pohl-Boskamp GmbH & Co. KG, and Universitätsklinikum Hamburg-Eppendorf.
Recent Clinical Trials for Dimethicone
|Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy||University of British Columbia||Phase 1/Phase 2|
|Topical Use of Difinsa53™ to Prevent Radiation Dermatitis||Poudre Valley Health System||Phase 1/Phase 2|
|Topical Use of Difinsa53™ to Prevent Radiation Dermatitis||ProTechSure Scientific, Inc.||Phase 1/Phase 2|